Saturday, August 27, 2022 12:43:12 AM
The Palm Springs hospital received both oral and IV forms of the medication on Aug. 22, explained Dr. Claudia Fortiche, manager of the research program at Desert Regional. The oral medication, typically three tablets taken twice a day, is the preferred treatment method, Foriche said, but an IV is available for patients who are experiencing painful mouth lesions that make it difficult to swallow. Once a patient is able to swallow, the CDC recommends that they switch to the oral form, Foriche said.
https://eu.desertsun.com/story/news/health/2022/08/26/desert-regional-medical-center-now-providing-tpoxx-medication-monkeypox-infections/7905491001/
$SIGA
https://eu.desertsun.com/story/news/health/2022/08/26/desert-regional-medical-center-now-providing-tpoxx-medication-monkeypox-infections/7905491001/
$SIGA
Recent SIGA News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/08/2026 08:01:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 08:48:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 08:08:35 PM
- SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update • GlobeNewswire Inc. • 05/07/2026 08:01:00 PM
- SIGA to Host Business Update Call on May 7, 2026, Following Release of First-Quarter 2026 Financial Results • GlobeNewswire Inc. • 04/30/2026 11:30:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/28/2026 08:04:31 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 08:03:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/28/2026 08:02:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 10:07:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 08:05:41 PM
- SIGA Declares Special Cash Dividend of $0.60 Per Share • GlobeNewswire Inc. • 03/26/2026 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:11:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:09:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:07:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:05:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 08:05:48 PM
- SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2025 and Provides Business Update • GlobeNewswire Inc. • 03/10/2026 08:01:00 PM
- SIGA to Host Business Update Call on March 10, 2026, Following Release of 2025 Financial Results • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2026 09:05:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2025 09:53:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/06/2025 09:06:30 PM
- SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2025 • GlobeNewswire Inc. • 11/06/2025 09:01:00 PM
- SIGA to Host Business Update Call on November 6, 2025 Following Release of Third-Quarter 2025 Results • GlobeNewswire Inc. • 10/30/2025 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/05/2025 08:53:57 PM
- SIGA Reports Financial Results for Three and Six Months Ended June 30, 2025 • GlobeNewswire Inc. • 08/05/2025 08:01:00 PM
